Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find the latest Drugs in Development and Pipeline Prospector News of Spiral Therapeutics.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Spiral Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
6000 Shoreline Ct, Suite 206, South San Francisco, CA 94080
Telephone
Telephone
+1 (650) 453-0893
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

SPT-2101 is a sustained-release steroid formulation designed for precise inner ear administration using Spiral's novel delivery procedure. Spiral recently completed enrollment of an open label pilot clinical study of SPT-2101 in 10 patients with Meniere's disease.


Lead Product(s): SPT-2101

Therapeutic Area: Otolaryngology (Ear, Nose, Throat) Product Name: SPT-2101

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: Savoir Capital

Deal Size: $8.2 million Upfront Cash: Undisclosed

Deal Type: Financing January 10, 2023

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY